Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Macrolide Antibiotics Global Market Report 2025
Request Sample Buy Now
Global Macrolide Antibiotics Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Macrolide Antibiotics Global Market Report 2025

By Drugs (Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, Telithromycin), By Indication (Respiratory Tract Infections, Skin Infections, Sexually Transmitted Infections, Gastrointestinal Infections, Other Indications), By Route Of Administration (Oral, Parenteral, Other Route Of Administrations), By Distribution Channel (Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers), By End User (Hospital, Dermatology Clinic, Clinic, Ambulatory Centre, Research Laboratories) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Macrolide Antibiotics Market Overview

• Macrolide Antibiotics market size has reached to $59.07 billion in 2024

• Expected to grow to $97.96 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%

• Growth Driver: Rising Prevalence Of Skin Infections Fuels Growth In The Macrolide Antibiotics Market

• Market Trend: Growing Emphasis On Generic Formulations In The Macrolide Antibiotic Market

• North America was the largest region in 2024.

What Is Covered Under Macrolide Antibiotics Market?

Macrolide antibiotics are a class of antibiotics characterized by a macrocyclic lactone ring with one or more sugars attached. They inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, making them effective against various Gram-positive and some Gram-negative bacteria.

The main drug types of macrolide antibiotics are azithromycin, clarithromycin, erythromycin, fidaxomicin, and telithromycin. Azithromycin is an antibiotic belonging to the macrolide class and works by inhibiting the growth of bacteria by interfering with their protein synthesis. The indication includes respiratory tract infections, Skin Infections, Sexually Transmitted Infections, gastrointestinal infections, and others and the route of administration are oral, parenteral, and others. The distribution channels used are hospital pharmacies, drug stores retail pharmacies, and online providers and IT is used by various end users such as hospitals, dermatology clinics, clinics, ambulatory centers, and research laboratories.

Macrolide Antibiotics Market Size and growth rate 2025 to 2029: Graph

What Is The Macrolide Antibiotics Market Size 2025 And Growth Rate?

The macrolide antibiotics market size has grown rapidly in recent years. It will grow from $59.07 billion in 2024 to $65.42 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increasing antibiotic resistance, approvals for new formulations, a rise in infectious diseases, and government and healthcare initiatives.

What Is The Macrolide Antibiotics Market Growth Forecast?

The macrolide antibiotics market size is expected to see rapid growth in the next few years. It will grow to $97.96 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to a rise in respiratory infections due to factors like arise in respiratory infections, rise in combination therapies, an increase in the global geriatric population, increased awareness and diagnostics, and growth in telemedicine and online pharmacy services. Major trends in the forecast period include advancements in drug delivery systems and formulations, the development of novel macrolide antibiotics, advancements in telemedicine and remote healthcare services, and the development of eco-friendly manufacturing processes for macrolide antibiotics.

The forecast of 10.6% growth over the next five years reflects a modest reduction of 0.9% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. adoption of macrolide antibiotics by inflating prices of azithromycin and clarithromycin formulations developed in India and Ireland, resulting in delayed infection management and higher infectious disease care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Macrolide Antibiotics Market Segmented?

1) By Drugs: Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, Telithromycin

2) By Indication: Respiratory Tract Infections, Skin Infections, Sexually Transmitted Infections, Gastrointestinal Infections, Other Indications

3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

4) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers

5) By End User: Hospital, Dermatology Clinic, Clinic, Ambulatory Centre, Research Laboratories

Subsegments:

1) By Azithromycin: Oral Tablets, Oral Suspension, Injection

2) By Clarithromycin: Immediate-Release Tablets, Extended-Release Tablets, Oral Suspension

3) By Erythromycin: Tablets, Capsules, Topical Solution, Injection

4) By Fidaxomicin: Oral Tablets

5) By Telithromycin: Oral Tablets

What Is Driving The Macrolide Antibiotics Market? Rising Prevalence Of Skin Infections Fuels Growth In The Macrolide Antibiotics Market

The increasing prevalence of skin infections is expected to propel the growth of the macrolide antibiotics market going forward. A skin infection is a condition caused by the invasion of harmful microorganisms into the skin, leading to inflammation and often accompanied by symptoms such as redness, swelling, and pain. Growing skin infections may result from factors such as poor hygiene practices, compromised immune systems, exposure to environmental pollutants, antibiotic resistance, and inadequate wound care. Macrolide antibiotics are often prescribed for treating skin infections caused by bacteria such as Staphylococcus aureus or Streptococcus pyogenes, particularly in cases of penicillin allergy or resistance. For instance, in September 2022, according to the UK Health Security Agency (UKHSA), a UK-based national executive agency, the percentage of Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia cases attributed to skin and soft tissue infections rose from 25.7% in the financial year April 2020 to March 2021 to 33.7% in the financial year April 2021 to March 2022. Similarly, for Methicillin-Sensitive Staphylococcus aureus (MSSA) bacteremia cases, the percentage increased from 27.2% to 28.5% over the same period. Therefore, the increasing prevalence of skin infections is driving the growth of the macrolide antibiotics industry.

Who Are The Major Players In The Global Macrolide Antibiotics Market?

Major companies operating in the macrolide antibiotics market are Pfizer Inc., Roche Holding AG, Merck Sharp & Dohme Corp, AbbVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc., Eli Lily and Company, Amgen Inc., Teva Pharmaceutical Industries Limited, Mylan N.V., Daiichi Sankyo, Sun Pharmaceutical Industries Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Zhejiang Guobang Pharmaceutical Co. Ltd., Fresenius Kabi USA, WOCKHARDT, Crescent Pharma Limited, Wellona Pharma Private Limited

What Are The Key Trends Of The Global Macrolide Antibiotics Market? Growing Emphasis On Generic Formulations In The Macrolide Antibiotic Market

Major companies operating in the macrolide antibiotic market are focusing on developing generic formulations to increase accessibility, reduce treatment costs, and expand their market reach. Generic formulations of macrolide antibiotics are non-branded versions of these drugs that contain the same active ingredients, dosage, and strength as the original branded medications. For instance, in May 2022, Phantom Pharmaceuticals, a US-based pharmaceutical company, launched two products, VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK, both designed for the treatment of Helicobacter pylori (H. pylori) infection in adults. VOQUEZNA TRIPLE PAK contains vonoprazan, a potassium-competitive acid blocker (PCAB), along with amoxicillin and clarithromycin, while VOQUEZNA DUAL PAK contains vonoprazan and amoxicillin. These treatments are innovative because vonoprazan represents the first new class of acid suppressants approved in the U.S. in over 30 years.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Macrolide Antibiotics Market? Aztiq Acquires Adalvo To Accelerate Growth In The Macrolide Antibiotics Market

In April 2024, Aztiq, an Iceland-based long-term investment fund, acquired Alvogen Emerging Markets Holdings Limited, the parent company of Adalvo for an undisclosed amount. The deal aims to accelerate Adalvo's growth and expansion, leveraging the combined strengths of Aztiq and Innobic (Asia), a wholly-owned Life Science arm of PTT. Adalvo is a US-based pharmaceutical company that provides macrolide antibiotics.

What Is The Regional Outlook For The Global Macrolide Antibiotics Market?

North America was the largest region in the macrolide antibiotics market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Macrolide Antibiotics Market?

The macrolide antibiotics market consists of sales of oral tablets and capsules such as dirithromycin, josamycin, spiramycin, and roxithromycin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Macrolide Antibiotics Industry?

The macrolide antibiotics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the macrolide antibiotics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Macrolide Antibiotics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $65.42 billion
Revenue Forecast In 2034 $97.96 billion
Growth Rate CAGR of 10.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drugs: Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin, Telithromycin
2) By Indication: Respiratory Tract Infections, Skin Infections, Sexually Transmitted Infections, Gastrointestinal Infections, Other Indications
3) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations
4) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
5) By End User: Hospital, Dermatology Clinic, Clinic, Ambulatory Centre, Research Laboratories Subsegments: 1) By Azithromycin: Oral Tablets, Oral Suspension, Injection
2) By Clarithromycin: Immediate-Release Tablets, Extended-Release Tablets, Oral Suspension
3) By Erythromycin: Tablets, Capsules, Topical Solution, Injection
4) By Fidaxomicin: Oral Tablets
5) By Telithromycin: Oral Tablets
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Roche Holding AG, Merck Sharp & Dohme Corp, AbbVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc., Eli Lily and Company, Amgen Inc., Teva Pharmaceutical Industries Limited, Mylan N.V., Daiichi Sankyo, Sun Pharmaceutical Industries Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Zhejiang Guobang Pharmaceutical Co. Ltd., Fresenius Kabi USA, WOCKHARDT, Crescent Pharma Limited, Wellona Pharma Private Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Macrolide Antibiotics Market Characteristics

3. Macrolide Antibiotics Market Trends And Strategies

4. Macrolide Antibiotics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Macrolide Antibiotics Growth Analysis And Strategic Analysis Framework

5.1. Global Macrolide Antibiotics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Macrolide Antibiotics Market Growth Rate Analysis

5.4. Global Macrolide Antibiotics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Macrolide Antibiotics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Macrolide Antibiotics Total Addressable Market (TAM)

6. Macrolide Antibiotics Market Segmentation

6.1. Global Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Azithromycin

Clarithromycin

Erythromycin

Fidaxomicin

Telithromycin

6.2. Global Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Respiratory Tract Infections

Skin Infections

Sexually Transmitted Infections

Gastrointestinal Infections

Other Indications

6.3. Global Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Other Route Of Administrations

6.4. Global Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Drug Stores And Retail Pharmacies

Online Providers

6.5. Global Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital

Dermatology Clinic

Clinic

Ambulatory Centre

Research Laboratories

6.6. Global Macrolide Antibiotics Market, Sub-Segmentation Of Azithromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Tablets

Oral Suspension

Injection

6.7. Global Macrolide Antibiotics Market, Sub-Segmentation Of Clarithromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immediate-Release Tablets

Extended-Release Tablets

Oral Suspension

6.8. Global Macrolide Antibiotics Market, Sub-Segmentation Of Erythromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Capsules

Topical Solution

Injection

6.9. Global Macrolide Antibiotics Market, Sub-Segmentation Of Fidaxomicin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Tablets

6.10. Global Macrolide Antibiotics Market, Sub-Segmentation Of Telithromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Tablets

7. Macrolide Antibiotics Market Regional And Country Analysis

7.1. Global Macrolide Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Macrolide Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Macrolide Antibiotics Market

8.1. Asia-Pacific Macrolide Antibiotics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Macrolide Antibiotics Market

9.1. China Macrolide Antibiotics Market Overview

9.2. China Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Macrolide Antibiotics Market

10.1. India Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Macrolide Antibiotics Market

11.1. Japan Macrolide Antibiotics Market Overview

11.2. Japan Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Macrolide Antibiotics Market

12.1. Australia Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Macrolide Antibiotics Market

13.1. Indonesia Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Macrolide Antibiotics Market

14.1. South Korea Macrolide Antibiotics Market Overview

14.2. South Korea Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Macrolide Antibiotics Market

15.1. Western Europe Macrolide Antibiotics Market Overview

15.2. Western Europe Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Macrolide Antibiotics Market

16.1. UK Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Macrolide Antibiotics Market

17.1. Germany Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Macrolide Antibiotics Market

18.1. France Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Macrolide Antibiotics Market

19.1. Italy Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Macrolide Antibiotics Market

20.1. Spain Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Macrolide Antibiotics Market

21.1. Eastern Europe Macrolide Antibiotics Market Overview

21.2. Eastern Europe Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Macrolide Antibiotics Market

22.1. Russia Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Macrolide Antibiotics Market

23.1. North America Macrolide Antibiotics Market Overview

23.2. North America Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Macrolide Antibiotics Market

24.1. USA Macrolide Antibiotics Market Overview

24.2. USA Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Macrolide Antibiotics Market

25.1. Canada Macrolide Antibiotics Market Overview

25.2. Canada Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Macrolide Antibiotics Market

26.1. South America Macrolide Antibiotics Market Overview

26.2. South America Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Macrolide Antibiotics Market

27.1. Brazil Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Macrolide Antibiotics Market

28.1. Middle East Macrolide Antibiotics Market Overview

28.2. Middle East Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Macrolide Antibiotics Market

29.1. Africa Macrolide Antibiotics Market Overview

29.2. Africa Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Macrolide Antibiotics Market Competitive Landscape And Company Profiles

30.1. Macrolide Antibiotics Market Competitive Landscape

30.2. Macrolide Antibiotics Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck Sharp & Dohme Corp Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Macrolide Antibiotics Market Other Major And Innovative Companies

31.1. Sanofi S.A

31.2. Bristol-Myers Squibb Company

31.3. Abbott Laboratories

31.4. Novartis AG

31.5. GlaxoSmithKline plc.

31.6. Eli Lily and Company

31.7. Amgen Inc.

31.8. Teva Pharmaceutical Industries Limited

31.9. Mylan N.V.

31.10. Daiichi Sankyo

31.11. Sun Pharmaceutical Industries Limited

31.12. Cipla Limited

31.13. Lupin Limited

31.14. Zydus Lifesciences Limited

31.15. Alkem Laboratories Ltd.

32. Global Macrolide Antibiotics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Macrolide Antibiotics Market

34. Recent Developments In The Macrolide Antibiotics Market

35. Macrolide Antibiotics Market High Potential Countries, Segments and Strategies

35.1 Macrolide Antibiotics Market In 2029 - Countries Offering Most New Opportunities

35.2 Macrolide Antibiotics Market In 2029 - Segments Offering Most New Opportunities

35.3 Macrolide Antibiotics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Macrolide Antibiotics Market, Sub-Segmentation Of Azithromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Macrolide Antibiotics Market, Sub-Segmentation Of Clarithromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Macrolide Antibiotics Market, Sub-Segmentation Of Erythromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Macrolide Antibiotics Market, Sub-Segmentation Of Fidaxomicin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Macrolide Antibiotics Market, Sub-Segmentation Of Telithromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Macrolide Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Macrolide Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Pfizer Inc. Financial Performance
  • Table 82: Roche Holding AG Financial Performance
  • Table 83: Merck Sharp & Dohme Corp Financial Performance
  • Table 84: AbbVie Inc. Financial Performance
  • Table 85: Bayer AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Macrolide Antibiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Macrolide Antibiotics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Macrolide Antibiotics Market, Sub-Segmentation Of Azithromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Macrolide Antibiotics Market, Sub-Segmentation Of Clarithromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Macrolide Antibiotics Market, Sub-Segmentation Of Erythromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Macrolide Antibiotics Market, Sub-Segmentation Of Fidaxomicin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Macrolide Antibiotics Market, Sub-Segmentation Of Telithromycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Macrolide Antibiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Macrolide Antibiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Macrolide Antibiotics Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Macrolide Antibiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Macrolide Antibiotics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Pfizer Inc. Financial Performance
  • Figure 82: Roche Holding AG Financial Performance
  • Figure 83: Merck Sharp & Dohme Corp Financial Performance
  • Figure 84: AbbVie Inc. Financial Performance
  • Figure 85: Bayer AG Financial Performance

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Read More About Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Review key data-driven trends shaping the global data storage market in 2025.

Read More About Review key data-driven trends shaping the global data storage market in 2025.

Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Read More About Analyze the 6.7% CAGR growth trajectory and strategic trends shaping the global medical glass vaccine bottles market through 2029.

Sheep And Goat Pox Vaccines Global Market Report 2025 – By Type (Live Attenuated Vaccines, Inactivated Vaccines, Other Types), By Route Of Administration (Injectable, Intranasal), By Application (Sheep, Goat) – Impact of...

View Report

Luxury Electric Vehicles Global Market Report 2025 – By Type (Battery Electric Vehicle (BEV), Plug-In Hybrid Electric Vehicles (PHEVs), Fuel Cell Electric Vehicles (FCEVs), Hybrid), By Battery Type (Lead-Acid, Lithium-Io...

View Report

Feed Mycotoxin Binders And Modifiers Global Market Report 2025 – By Type (Feed Mycotoxin Binders, Feed Mycotoxin Modifiers), By Source (Inorganic , Organic), By Livestock (Poultry, Swine, Ruminants, Aquatic Animals, Othe...

View Report

Veterinary Antibiotics Global Market Report 2025 – By Product (Anti-parasitic, Anti-bacterial, Non-steroidal anti-inflammatory drug, Others), By End User (Farm Animals , Companion Animals), By Administration (Premixes, I...

View Report

Microscope Global Market Report 2025 – By Product (Optical, Electron, Scanning Probe, Other Products), By Component (Microscopes, Accessories, Software), By Application (Material Science, Nanotechnology, Life Science, Se...

View Report

Truck Mounted Crane Global Market Report 2025 – By Type (Articulating Cranes, Hydraulic Cranes, Telescopic Cranes, Other Types), By Drive (Electrical, Mechanical, Hydraulic), By Lifting Capacity (Below 15 Ton, 15 to 30 T...

View Report

Commercial Vehicle Telematics Global Market Report 2025 – By Type (Solutions, Services), By Provider Type (Original Equipment Manufacturer (OEM), Aftermarket), By Vertical (Transportation And Logistics, Government And Ut...

View Report

Data Center Cooling Global Market Report 2025 – By Data Centre Type (Large Data Centers, Enterprise Data Centers, Mid-sized Data Centers), By Cooling Technology (Rack/Row-Based, Room-Based), By Component (Solution, Servi...

View Report

Frequently Asked Questions

Macrolide antibiotics are a class of antibiotics characterized by a macrocyclic lactone ring with one or more sugars attached. They inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit, making them effective against various Gram-positive and some Gram-negative bacteria. For further insights on this market, request a sample here

The market major growth driver - Rising Prevalence Of Skin Infections Fuels Growth In The Macrolide Antibiotics Market. For further insights on this market, request a sample here

The macrolide antibiotics market size has grown rapidly in recent years. It will grow from $59.07 billion in 2024 to $65.42 billion in 2025 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to increasing antibiotic resistance, approvals for new formulations, a rise in infectious diseases, and government and healthcare initiatives. The macrolide antibiotics market size is expected to see rapid growth in the next few years. It will grow to " $97.96 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to a rise in respiratory infections due to factors like arise in respiratory infections, rise in combination therapies, an increase in the global geriatric population, increased awareness and diagnostics, and growth in telemedicine and online pharmacy services. Major trends in the forecast period include advancements in drug delivery systems and formulations, the development of novel macrolide antibiotics, advancements in telemedicine and remote healthcare services, and the development of eco-friendly manufacturing processes for macrolide antibiotics. For further insights on this market, request a sample here

The macrolide antibioticsmarket covered in this report is segmented –
1) By Drugs: Azithromycin; Clarithromycin; Erythromycin; Fidaxomicin; Telithromycin
2) By Indication: Respiratory Tract Infections; Skin Infections; Sexually Transmitted Infections; Gastrointestinal Infections; Other Indications
3) By Route Of Administration: Oral; Parenteral; Other Route Of Administrations
4) By Distribution Channel: Hospital Pharmacies; Drug Stores And Retail Pharmacies; Online Providers
5) By End User: Hospital; Dermatology Clinic; Clinic; Ambulatory Centre; Research Laboratories Subsegments:
1) By Azithromycin: Oral Tablets; Oral Suspension; Injection
2) By Clarithromycin: Immediate-Release Tablets; Extended-Release Tablets; Oral Suspension
3) By Erythromycin: Tablets; Capsules; Topical Solution; Injection
4) By Fidaxomicin: Oral Tablets
5) By Telithromycin: Oral Tablets For further insights on this market, request a sample here

North America was the largest region in the macrolide antibiotics market in 2024. The regions covered in the macrolide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the macrolide antibiotics market are Pfizer Inc., Roche Holding AG, Merck Sharp & Dohme Corp, AbbVie Inc., Bayer AG, Sanofi S.A, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc., Eli Lily and Company, Amgen Inc., Teva Pharmaceutical Industries Limited, Mylan N.V., Daiichi Sankyō, Sun Pharmaceutical Industries Limited, Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Zhejiang Guobang Pharmaceutical Co. Ltd., Fresenius Kabi USA, WOCKHARDT, Crescent Pharma Limited, Wellona Pharma Private Limited . For further insights on this market, request a sample here.

Major trends in this market include Growing Emphasis On Generic Formulations In The Macrolide Antibiotic Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Macrolide Antibiotics Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon